These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 24275248)

  • 1. Synthesis and biological evaluation of new epalrestat analogues as aldose reductase inhibitors (ARIs).
    Reddy TN; Ravinder M; Bagul P; Ravikanti K; Bagul C; Nanubolu JB; Srinivas K; Banerjee SK; Rao VJ
    Eur J Med Chem; 2014 Jan; 71():53-66. PubMed ID: 24275248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quinazolinone-based rhodanine-3-acetic acids as potent aldose reductase inhibitors: Synthesis, functional evaluation and molecular modeling study.
    El-Sayed S; Metwally K; El-Shanawani AA; Abdel-Aziz LM; El-Rashedy AA; Soliman MES; Quattrini L; Coviello V; la Motta C
    Bioorg Med Chem Lett; 2017 Oct; 27(20):4760-4764. PubMed ID: 28935265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis and evaluation of rhodanine derivatives as aldose reductase inhibitors.
    Agrawal YP; Agrawal MY; Gupta AK
    Chem Biol Drug Des; 2015 Feb; 85(2):172-80. PubMed ID: 24903533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. (4-Oxo-2-thioxothiazolidin-3-yl)acetic acids as potent and selective aldose reductase inhibitors.
    Kucerova-Chlupacova M; Halakova D; Majekova M; Treml J; Stefek M; Soltesova Prnova M
    Chem Biol Interact; 2020 Dec; 332():109286. PubMed ID: 33038328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epalrestat, an Aldose Reductase Inhibitor Prevents Glucose-Induced Toxicity in Human Retinal Pigment Epithelial Cells In Vitro.
    Senthilkumari S; Sharmila R; Chidambaranathan G; Vanniarajan A
    J Ocul Pharmacol Ther; 2017; 33(1):34-41. PubMed ID: 27835059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 6,7-Dihydroxy-4-phenylcoumarin as inhibitor of aldose reductase 2.
    Kato A; Kobayashi K; Narukawa K; Minoshima Y; Adachi I; Hirono S; Nash RJ
    Bioorg Med Chem Lett; 2010 Oct; 20(19):5630-3. PubMed ID: 20805028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro studies of potent aldose reductase inhibitors: Synthesis, characterization, biological evaluation and docking analysis of rhodanine-3-hippuric acid derivatives.
    Celestina SK; Sundaram K; Ravi S
    Bioorg Chem; 2020 Apr; 97():103640. PubMed ID: 32086051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Docking and molecular dynamics studies toward the binding of new natural phenolic marine inhibitors and aldose reductase.
    Wang Z; Ling B; Zhang R; Suo Y; Liu Y; Yu Z; Liu C
    J Mol Graph Model; 2009 Sep; 28(2):162-9. PubMed ID: 19616461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective Effects of Novel Substituted Triazinoindole Inhibitors of Aldose Reductase and Epalrestat in Neuron-like PC12 Cells and BV2 Rodent Microglial Cells Exposed to Toxic Models of Oxidative Stress: Comparison with the Pyridoindole Antioxidant Stobadine.
    Elmazoglu Z; Prnova MS; Stefek M; Ceylan AF; Aschner M; Rangel-López E; Santamaria A; Karasu C
    Neurotox Res; 2021 Jun; 39(3):588-597. PubMed ID: 33713301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of lignans extracted from Eucommia ulmoides and aldose reductase inhibitor epalrestat on hypertensive vascular remodeling.
    Gu J; Wang JJ; Yan J; Cui CF; Wu WH; Li L; Wang ZS; Yu M; Gao N; Liu L; Ouyang DS
    J Ethnopharmacol; 2011 Jan; 133(1):6-13. PubMed ID: 20817083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Inhibition effect of epalrestat on rat lens osmotic expansion].
    Ji LX; Shen N; Li CN; Liu Q; Huan Y; Shen ZF
    Yao Xue Xue Bao; 2009 Oct; 44(10):1107-11. PubMed ID: 20055132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, activity, and molecular modeling of new 2, 4-dioxo-5-(naphthylmethylene)-3-thiazolidineacetic acids and 2-thioxo analogues as potent aldose reductase inhibitors.
    Fresneau P; Cussac M; Morand JM; Szymonski B; Tranqui D; Leclerc G
    J Med Chem; 1998 Nov; 41(24):4706-15. PubMed ID: 9822541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term clinical effects of epalrestat, an aldose reductase inhibitor, on progression of diabetic neuropathy and other microvascular complications: multivariate epidemiological analysis based on patient background factors and severity of diabetic neuropathy.
    Hotta N; Kawamori R; Fukuda M; Shigeta Y;
    Diabet Med; 2012 Dec; 29(12):1529-33. PubMed ID: 22507139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-activity relationships and molecular modelling of new 5-arylidene-4-thiazolidinone derivatives as aldose reductase inhibitors and potential anti-inflammatory agents.
    Maccari R; Vitale RM; Ottanà R; Rocchiccioli M; Marrazzo A; Cardile V; Graziano AC; Amodeo P; Mura U; Del Corso A
    Eur J Med Chem; 2014 Jun; 81():1-14. PubMed ID: 24819954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ranirestat has a stronger inhibitory activity on aldose reductase and suppresses inflammatory reactions in high glucose-exposed endothelial cells.
    Ishibashi Y; Matsui T; Matsumoto T; Kato H; Yamagishi S
    Diab Vasc Dis Res; 2016 Jul; 13(4):312-5. PubMed ID: 27190083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro evaluation of 5-arylidene-2-thioxo-4-thiazolidinones active as aldose reductase inhibitors.
    Maccari R; Del Corso A; Giglio M; Moschini R; Mura U; Ottanà R
    Bioorg Med Chem Lett; 2011 Jan; 21(1):200-3. PubMed ID: 21129963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epalrestat improves diabetic wound healing via increased expression of nerve growth factor.
    Nakagaki O; Miyoshi H; Sawada T; Atsumi T; Kondo T; Atsumi T
    Exp Clin Endocrinol Diabetes; 2013 Feb; 121(2):84-9. PubMed ID: 23426701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular modeling studies of the binding modes of aldose reductase inhibitors at the active site of human aldose reductase.
    Lee YS; Chen Z; Kador PF
    Bioorg Med Chem; 1998 Oct; 6(10):1811-9. PubMed ID: 9839011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epalrestat: an aldose reductase inhibitor for the treatment of diabetic neuropathy.
    Ramirez MA; Borja NL
    Pharmacotherapy; 2008 May; 28(5):646-55. PubMed ID: 18447661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenolic marine natural products as aldose reductase inhibitors.
    Manzanaro S; Salva J; de la Fuente JA
    J Nat Prod; 2006 Oct; 69(10):1485-7. PubMed ID: 17067167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.